Identification of 14-3-3ζ by chemical affinity with salicylanilide inhibitors of interleukin-12p40 production

Bioconjugate Chemistry

Volumn 19, Issue 9, 2008, Pages 1775-1784

  Boyce, Jim P ^a   Brown, Michael E ^a   Chin, Wilson ^a   Fitzner, Jeffrey N ^a   Paxton, Raymond J ^a   Shen, Min ^a   Stevens, Tracey ^a   Wolfson, Martin F ^a   Wright, Clifford D ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVES; CHEMICAL AFFINITIES; DENDRITICS; DERIVATIZATIONS; MATRIX; SALICYLANILIDE; SELECTIVE INHIBITORS;

AFFINITY CHROMATOGRAPHY;

FUNCTIONAL GROUP; INTERLEUKIN 12P40; PROTEIN 14 3 3; PROTEIN 14 3 3ZETA; REAGENT; SALICYLANILIDE DERIVATIVE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DERIVATIZATION; DRUG PROTEIN BINDING; MASS SPECTROMETRY; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 52249084140     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800078q     Document Type: Article

References (19)

1. Trinchieri, G., Pflanz, S., and Kastelein, R. A. (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641-644.
2. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., and Presky, D. H. (1998) The Interleukine-12/interleukine-12- receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495-521.
3. Toichi, E., Torres, G., McCormick, T. S., Chang, T., Mascelli, M. A., Kauffman, C. L., Aria, N., Gottlieb, A. B., Everitt, D. E., Frederick, B., Pendley, C. E., and Cooper, K. D. (2006) An Anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J. Immunol. 177 (7), 4917-4926.
4. Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., Quezado, M., Neurath, M. F., Salfeld, J., Veldman, G. M., Schwertschlag, U., and Strober, W. (2004) Anti-interleukin-12 antibody for active Crohn's disease. New Engl. J. Med. 351, 2069-2079.
5. Burakoff, R., Barish, C. F., Riff, D., Pruitt, R., Chey, W. Y., Farraye, F. A., Shafran, I., Katz, S., Krone, C. L., Vander, V. M., Stevens, C., Sherman, M. L., Jacobson, E., and Bleday, R. (2006) A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflammatory Bowel Diseases 12 (7), 558-565.
6. Coopera, A. M., and Khader, S. A. (2007) IL-12p40: an inherently agonistic cytokine. Trends Immunol. 28 (1), 33-38.
7. Agrawal, V. K., and Sharma, S. (1984) Salicylanilides in the treatment of helminth diseases. Pharmazie 39 (6), 373-378.
8. Kasckow, J. W., Tabira, T., Itoyama, Y., Kuroiwa, Y., Takenaka, A., and Nagai, Y. (1981) Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug. Jpn. J. Exp. Med. 51 (5), 293-298.
9. Zhu, X.-F., Wang, J.-S., Cai, L.-L., Zeng, Y.-X., and Yang, D. (2006) SUCI-02 inhibits the ErbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells. Cancer Sci. 97 (1), 84-89.
10. Waisser, K., Matyk, J., Divišová, H., Husá ková, P., Kuneš, J., Klimešová, V., Kaustová, J., Möllmann, U., Dahse, H.-M., and Miko, M. (2006) The oriented development of antituberculotics: salicylanilides. Arch. Pharm 339 (11), 616-620.
11. Eriksson, U., Kurrer, M. O., Sonderegger, I., Iezzi, G., Tafuri, A., Hunziker, L., Suzuki, S., Bachmaier, K., Bingisser, R. M., Penninger, J. M., and Kopf, M. (2003) Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J. Exp. Med. 197 (3), 323-331.
12. Pasare, C., and Medzhitov, R. (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (5609), 1033-1036.
13. Johnson, R. S., Davis, M. T., Taylor, J. A., and Patterson, S. D. (2005) Methods 35 (3), 223-236.
14. Macdonald, N., Welburn, J. P. I., Noble, M. E. M., Nguyen, A., Yaffe, M. B., Clynes, D., Moggs, J. G., Orphanides, G., Thomson, S., Edmunds, J. W., Clayton, A. L., Endicott, J. A., and Mahadevan, L. C. (2005) Molecular basis for the recognition of phosphorylated and phosphoacetylated histone H3 by 14-3-3. Mol. Cell 20 (2), 199-211.
15. Unpublished results.
16. Thomas, D., Guthridge, M., Woodcock, J., and Lopez, A. (2005) 14-3-3 protein signaling in development and growth factor responses. Curr. Top. Dev. Biol. 67, 285-303.
17. Aitken, A. (2006) 14-3-3 proteins: A historic overview. Semin. Cancer Biol. 16 (3), 162-172.
18. Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., and Amigorena, S. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166 (12), 7309-7318.
19. Fu, H., Subramanian, R. R., and Masters, S. C. (2000) 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40, 617-647.